Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria A Argiriadi

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
BMC Structural Biology|January 13, 2006
Crystal structure of a DNA polymerase sliding clamp from a Gram-positive bacteriumMaria A Argiriadi, Eric R Goedken, Irina Bruck, et al.
The Journal of Biological Chemistry|June 26, 2009
Unusual water-mediated antigenic recognition of the proinflammatory cytokine interleukin-18Maria A Argiriadi, Tao Xiang, Chengbin Wu, et al.
Progress in Medicinal Chemistry|March 19, 2019
Covalent binders in drug discoveryAnil Vasudevan, Maria A Argiriadi, Aleksandra Baranczak, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 2016
Creation of a S1P Lyase bacterial surrogate for structure-based drug designMaria A Argiriadi, David Banach, Elzbieta Radziejewska, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2016
Hit-to-lead evaluation of a novel class of sphingosine 1-phosphate lyase inhibitorsJurgen Dinges, Christopher M Harris, Grier A Wallace, et al.
Journal of Medicinal Chemistry|September 26, 2014
Optimized protein kinase Cθ (PKCθ) inhibitors reveal only modest anti-inflammatory efficacy in a rodent model of arthritisDawn M George, Eric C Breinlinger, Maria A Argiriadi, et al.
BMC Structural Biology|March 20, 2009
Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case studyMaria A Argiriadi, Silvino Sousa, David Banach, et al.
BMC Molecular and Cell Biology|August 7, 2019
CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switchesMaria A Argiriadi, Lorenzo Benatuil, Ievgeniia Dubrovska, et al.
BMC Structural Biology|September 22, 2012
Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitorMaria A Argiriadi, Eric R Goedken, David Banach, et al.
The Journal of Biological Chemistry|January 2, 2015
Tricyclic covalent inhibitors selectively target Jak3 through an active site thiolEric R Goedken, Maria A Argiriadi, David L Banach, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
BMC Structural Biology|January 13, 2006
Crystal structure of a DNA polymerase sliding clamp from a Gram-positive bacteriumMaria A Argiriadi, Eric R Goedken, Irina Bruck, et al.
The Journal of Biological Chemistry|June 26, 2009
Unusual water-mediated antigenic recognition of the proinflammatory cytokine interleukin-18Maria A Argiriadi, Tao Xiang, Chengbin Wu, et al.
Progress in Medicinal Chemistry|March 19, 2019
Covalent binders in drug discoveryAnil Vasudevan, Maria A Argiriadi, Aleksandra Baranczak, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 2016
Creation of a S1P Lyase bacterial surrogate for structure-based drug designMaria A Argiriadi, David Banach, Elzbieta Radziejewska, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2016
Hit-to-lead evaluation of a novel class of sphingosine 1-phosphate lyase inhibitorsJurgen Dinges, Christopher M Harris, Grier A Wallace, et al.
Journal of Medicinal Chemistry|September 26, 2014
Optimized protein kinase Cθ (PKCθ) inhibitors reveal only modest anti-inflammatory efficacy in a rodent model of arthritisDawn M George, Eric C Breinlinger, Maria A Argiriadi, et al.
BMC Structural Biology|March 20, 2009
Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case studyMaria A Argiriadi, Silvino Sousa, David Banach, et al.
BMC Molecular and Cell Biology|August 7, 2019
CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switchesMaria A Argiriadi, Lorenzo Benatuil, Ievgeniia Dubrovska, et al.
BMC Structural Biology|September 22, 2012
Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitorMaria A Argiriadi, Eric R Goedken, David Banach, et al.
The Journal of Biological Chemistry|January 2, 2015
Tricyclic covalent inhibitors selectively target Jak3 through an active site thiolEric R Goedken, Maria A Argiriadi, David L Banach, et al.
Pageof 2